Back to search
Benign Essential Blepharospasm
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Benign Essential Blepharospasm trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Benign Essential Blepharospasm trials you may qualify forThe goal of this clinical trial is to test the effects of DaxibotulinumtoxinA-Lanm (Daxxify) in patients with benign essential blepharospasms (BEB) and hemifaci…
To date, there is only limited knowledge about the distinct neural abnormalities that lead to the development of different forms of focal dystonia. The goal of…
This study aims to provide real-world information about the duration, safety, and overall benefit of DaxibotulinumtoxinA (also called DAXI) treatment for adults…
Efficient gait requires effective postural control, both static and dynamic. Hence, postural disorders may affect gait. Yet, very little is known about the spec…
This study is designed to assess the safety and tolerability of dipraglurant in patients with blepharospasm (BSP) (randomized 1:1:1 to receive dipraglurant 50 m…